Company: XERI
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001477932-25-001010
Chunk: 3

Company: XERIANT, INC.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
 of common shares outstanding - basic and diluted  596,196,491   423,465,699   571,876,754   408,569,551 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-3Table of Contents

XERIANT, INC.CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICITFOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2024UNAUDITED                                     Series A Preferred Stock    Series B Preferred Stock    Common Stock   stock  to be    Additional Paid in    Accumulated     Non-Controlling       Shares   Amount  Shares   Amount   Shares  Amount  issued   Capital   Deficit  Interest   Total  Balance June 30, 2024  705,895  $7   1,000,000  $10   524,853,304  $5,248  $51,950  $20,899,187  $(26,708,915) $(2,859,941) $(8,612,454)                                             Stock issued for services  -   -   -   -   11,902,182   119   -   217,393   -   -   217,512                                              Conversion of Series A Preferred to Common Stock  (6,479)  -   -   -   6,479,000   65   -   (65)  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   26,950,000   270   -   269,231   -   -   269,501                                              Net loss  -   -   -   -   -   -   -   -   (364,846)  (7,376)  (372,222)                                             Balance September